Weill Cornell Medicine investigators have pinpointed potential new strategies for treating depression by reverse engineering the antidepressant effects of ketamine. The research addresses the critical need for more effective treatments, as not all patients respond to the existing options available for depression.
The team of investigators conducted a detailed analysis of how ketamine works in the brain to alleviate depressive symptoms. Their reverse engineering approach allowed them to identify specific mechanisms and pathways responsible for ketamine’s antidepressant action. These findings may pave the way for the development of novel therapeutic interventions that can offer relief to a broader range of patients struggling with depression.
\n
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: May 1, 2026
發佈留言